Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease

被引：66
|
作者：
Shao, D [1 ]
Zou, CY [1 ]
Luo, C [1 ]
Tang, XC [1 ]
Li, YC [1 ]
机构：
[1] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 18期
关键词：
tacrine-E2020; hybrids; acetylcholinesterase inhibitor; Alzheimer's disease;
D O I：
10.1016/j.bmcl.2004.07.005
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Tacrine-E2020 hybrids and some related compounds were prepared and their bioactivities on the Alzheimer's disease were assayed. The optimum hybrid inhibitor 3 is 37-fold more potent and 31-fold more selective than tacrine in vitro. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4639 / 4642
页数：4
相关论文
共 50 条
  • [41] Synthesis and Biological Evaluation of Novel Tacrine Derivatives and Tacrine-Coumarin Hybrids as Cholinesterase Inhibitors
    Hamulakova, Slavka
    Janovec, Ladislav
    Hrabinova, Martina
    Spilovska, Katarina
    Korabecny, Jan
    Kristian, Pavol
    Kuca, Kamil
    Imrich, Jan
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (16) : 7073 - 7084
  • [42] Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease
    Spilovska, Katarina
    Korabecny, Jan
    Nepovimova, Eugenie
    Dolezal, Rafael
    Mezeiova, Eva
    Soukup, Ondrej
    Kuca, Kamil
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 1006 - 1026
  • [43] Design, synthesis and evaluation of novel coumarin-oxa/thiadiazole hybrids as AChE inhibitors for the treatment of alzheimer's disease
    Jaber, Tasneem
    More, Uttam A.
    Sidat, Parin
    Khan, Shabeena
    Jain, Payal
    Noolvi, Malleshappa N.
    Palkar, Mahesh B.
    INDIAN JOURNAL OF CHEMICAL TECHNOLOGY, 2024, 31 (03) : 483 - 493
  • [44] Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
    Marucci, Gabriella
    Buccioni, Michela
    Dal Ben, Diego
    Lambertucci, Catia
    Volpini, Rosaria
    Amenta, Francesco
    NEUROPHARMACOLOGY, 2021, 190
  • [45] Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease
    Hamulakova, Slavka
    Janovec, Ladislav
    Hrabinova, Martina
    Kristian, Pavol
    Kuca, Kamil
    Banasova, Maria
    Imrich, Jan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 23 - 31
  • [46] Tacrine-Natural-Product Hybrids for Alzheimer's Disease Therapy
    Jesus Oset-Gasque, Maria
    Luis Marco-Contelles, Jose
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (26) : 4392 - 4400
  • [47] Progress in acetylcholinesterase inhibitors for Alzheimer's disease
    Bolognesi, Maria Laura
    Minarini, Anna
    Tumiatti, Vincenzo
    Melchiorre, Carlo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (06) : 811 - 823
  • [48] Novel Vilazodone Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation
    Li, Xiaokang
    Wang, Huan
    Xu, Yixiang
    Liu, Wenwen
    Gong, Qi
    Wang, Wei
    Qiu, Xiaoxia
    Zhu, Jin
    Mao, Fei
    Zhang, Haiyan
    Li, Jian
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (12): : 2708 - 2721
  • [49] Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease
    Fu, Yingbo
    Mu, Yu
    Lei, Hui
    Wang, Pu
    Li, Xin
    Leng, Qiao
    Han, Li
    Qu, Xiaodan
    Wang, Zhanyou
    Huang, Xueshi
    MOLECULES, 2016, 21 (10)
  • [50] Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease
    Yao, Hong
    Uras, Giuseppe
    Zhang, Pengfei
    Xu, Shengtao
    Yin, Ying
    Liu, Jie
    Qin, Shuai
    Li, Xinuo
    Allen, Stephanie
    Bai, Renren
    Gong, Qi
    Zhang, Haiyan
    Zhu, Zheying
    Xu, Jinyi
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (11) : 7483 - 7506
12345